Palisade Bio, Inc. Profile Avatar - Palmy Investing

Palisade Bio, Inc.

Palisade Bio, Inc., a clinical-stage biopharmaceutical company, focuses on discovering, developing, and commercializing oral therapies that target serious diseases associated with the breakdown of the mucosal barrier protecting the gastrointestinal tract…

Biotechnology
US, Carlsbad [HQ]

Lobbying Analysis

Palisade Bio, Inc. has no lobbying expenses in our database.

History

Download
FY Quarter Expense For Lobby Disclosure LDA Reference
No data
End of PALI's Analysis
CIK: 1357459 CUSIP: 696389105 ISIN: US6963892046 LEI: - UEI: -
Secondary Listings
PALI has no secondary listings inside our databases.